Weekly Recap: Q3 sales, record EPS and 2026 guidance includes Millar

What happened

CTS Corporation reported third-quarter 2026 sales of $149.6 million, up 5% year over year, and record adjusted earnings per share of $0.77. It raised its 2026 sales guidance to $580–$590 million and adjusted earnings-per-share guidance to $2.78–$2.88. The company completed its Millar acquisition in October.

Confirmed

Global impact / market context

Higher guidance signals that CTS expects stronger full-year sales and earnings than before. Medical and industrial demand supported recent growth, while Millar adds medical-sensing products and is expected to contribute about $30 million in annual revenue and lift earnings per share in the second half of 2027.

Analyst inference

The update combines current operating results with expectations for a recently completed acquisition. CTS reported nine-month sales growth of 7.3%, with diversified-market sales up 7% and transportation up 2%, while aerospace and defense sales fell; this mix may shape future growth and profit per sale.

Analyst inference

What to watch

1. Compare later results with the raised 2026 sales range of $580–$590 million and adjusted earnings-per-share range of $2.78–$2.88 to see whether performance meets guidance. Analyst inference
2. Track whether Millar delivers the expected roughly $30 million in annual revenue and contributes to higher earnings per share in the second half of 2027. Analyst inference
3. Watch demand across medical, industrial, transportation, and aerospace and defense markets; the article reports growth in some areas but a decline in aerospace and defense. Confirmed

Evidence

• Original source link unavailable